Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells

Published:2015-11-03 Issue:3 Volume:30 Page:701-707
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Pinz K,Liu H,Golightly M,Jares A,Lan F,Zieve G W,Hagag N,Schuster M,Firor A E,Jiang X,Ma Y

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015311.pdf

Reference51 articles.

1. Firor AE, Jares A, Ma Y . From humble beginnings to success in the clinic: chimeric antigen receptor-modified T-cells and implications for immunotherapy. Exp Biol Med 2015; 240: 1087–1098.

2. Gill S, June CH . Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunol Rev 2015; 263: 68–89.

3. Skarbnik AP, Burki M, Pro B . Peripheral T-cell lymphomas: a review of current approaches and hopes for the future. Front Oncol 2013; 3: 138.

4. Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K . Peripheral T-cell lymphoma. Blood 2011; 117: 6756–6767.

5. Jonker M, Slingerland W, Treacy G, van Eerd P, Pak KY, Wilson E et al. In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. Clin Exp Immunol 1993; 93: 301–307.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T-cell therapy in cancer: Integrating nursing perspectives for enhanced patient care;Asia-Pacific Journal of Oncology Nursing;2024-10

2. In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma;Journal of Experimental & Clinical Cancer Research;2024-09-14

3. Efficient Capture and Traceless Release of Functional CD8⁺ T Cells with a Microfluidic Chip for Enhanced In Vitro and In Vivo CD4-CAR Transduction;Analytical Chemistry;2024-09-13

4. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

5. CAR T-cells for T-cell acute lymphoblastic leukemia;EJC Paediatric Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3